Poly(L-glutamic acid)-paclitaxel conjugate is a potent enhancer of tumor radiocurability
- 1 March 2003
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 55 (3) , 707-712
- https://doi.org/10.1016/s0360-3016(02)04153-6
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Rational development of capecitabinePublished by Elsevier ,2002
- Tirapazamine: Prototype for a novel class of therapeutic agents targeting tumor hypoxiaSeminars in Oncology, 2002
- Biology-based combined-modality radiotherapy: workshop reportInternational Journal of Radiation Oncology*Biology*Physics, 2001
- Pelvic Radiation with Concurrent Chemotherapy Compared with Pelvic and Para-Aortic Radiation for High-Risk Cervical CancerNew England Journal of Medicine, 1999
- Hyperfractionated Irradiation with or without Concurrent Chemotherapy for Locally Advanced Head and Neck CancerNew England Journal of Medicine, 1998
- In Vitro Studies of Taxol as a Radiation Sensitizer in Human Tumor CellsJNCI Journal of the National Cancer Institute, 1994
- Conjugates of anticancer agents and polymers: advantages of macromolecular therapeutics in vivoBioconjugate Chemistry, 1992
- Combined Chemotherapy and Radiotherapy Compared with Radiotherapy Alone in Patients with Cancer of the EsophagusNew England Journal of Medicine, 1992
- Response of previously irradiated mouse skin to a second course of irradiation: early skin reaction and skin shrinkageInternational Journal of Radiation Oncology*Biology*Physics, 1986
- Microcolony Survival Assay for Cells of Mouse Intestinal Mucosa Exposed to RadiationInternational Journal of Radiation Biology and Related Studies in Physics, Chemistry and Medicine, 1970